Skip to main content
Pamela Schlembach, MD, Radiation Oncology, Houston, TX

Pamela J. Schlembach MD

Breast Cancer, Central Nervous System Cancer


Professor Radiation Oncology and Center Medical Director MD Anderson Woodlands

Join to View Full Profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-792-6161

Dr. Schlembach is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Pamela Schlembach is a Radiation Oncologist based in Houston, TX, specializing in breast and central nervous system cancers. Educated at The University of Toledo College of Medicine, she completed her residency at the University of Texas MD Anderson Cancer Center where she joined the faculty. She has been serving as a professor in Radiation Oncology at MD Anderson Cancer Center since 2002 and has significant clinical and research experience. Dr. Schlembach is the center medical director of The MD Anderson Woodlands campus and has authored multiple publications, contributing to journals including the Journal of Clinical Oncology, with her work being cited several times. Her honors include awards for excellence in service and community outreach, and she has been recognized among Houston's influential women and nominated by her peers at MD Anderson in Radiation Oncology for her outstanding service.
  • Breast Friends Woodlands

    The Facebook page for our breast cancer support group.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1998 - 2002
  • The University of Toledo College of Medicine
    The University of Toledo College of MedicineClass of 1997
  • University of Toledo
    University of ToledoBS, Institutional Healthcare Management, 1992
  • Owens Technical College
    Owens Technical CollegeAD, Radiological Technology, 1977

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2028
  • GA State Medical License
    GA State Medical License 2023 - 2028
  • TN State Medical License
    TN State Medical License 2023 - 2028
  • LA State Medical License
    LA State Medical License 2023 - 2027
  • OK State Medical License
    OK State Medical License 2020 - 2027
  • AL State Medical License
    AL State Medical License 2023 - 2026
  • Radiation Oncology
    American Board of Radiology Radiation Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • Excellence in Service - Internal and Extramural Award in Radiation Oncology University of Texas MD Anderson Cancer Center, 2024
  • Community Outreach Excellence Award MD Anderson Faculty Excellence Award, 2023
  • Trailblazer Award 2022 Greater Houston Women's Summit, 2022

Publications & Presentations

PubMed

Journal Articles

  • Locoregional Management and Prognostic Factors in Breast Cancer Patients with Ipsilateral Internal Mammary and Axillary Lymph Node Involvment  
    Andring L, Woodward W, Schlembach, P, Smith B, International Journal of Radiation Oncology Biology Physics, 3/2022
  • Association of Transforming Growth Factor Β Polymorphism C−509T with Radiation-Induced Fibrosis Among Patients with Early-Stage Breast CancerA Secondary Analysis of a ...  
    Karen E Hoffman, Elizabeth S Bloom, Pamela J Schlembach, Thomas A Buchholz, Benjamin D Smith, Wendy A Woodward, Welela Tereffe, Simona F Shaitelman, Michael C Stauder, JAMA
  • 19. M Consideration of Patient Characteristics and Comorbidity in Selecting Candidates for Moderately Hypofractionated Radiation: Secondary analysis from a randomized ...  
    oningi S, Kuban D, Allen P, Choi S, Frank S, Nguyen Q, McGuire S, Skinner H, Schlembach P, Voong R, Hoffman K., Int J Radiat Oncol Biol Phys 99(2):S155-S156, 10/2017., 10/2017

Abstracts/Posters

  • Optimizing Houston Area Locations Ambulatory Radiation Oncology Consult Workflow Using Patient Flow Analysis with Real-Time Patient Tracking
    Weng J, Chronowski G, Smith R, Ehlers R, Schlembach P, Mayo L, Joyner, M, Shah S, Arzu I, Nguyen Q, American Radium Society, Scottsdale AZ, 5/19/2022
  • General Poster Session A: Science of Quality.
    Ballo, Matthew; Chronowski, Gregory;Schlembach, Pamela;Bloom, Elizabeth;Arzu, Isadora;Kuban, Deborah, J Clin Oncol, 1/1/2013
  • Comparison of Intensity Modulated Radiotherapy Versus Conventional Treatment Planning in Bilateral and Unilateral Post-Operative Thyroid Cancer
    Schlembach, Pamela J, American Radium Society, Houston, TX, 1/1/2003

Lectures

  • Breast Cancer Updates 
    Instanbul, Turkey - 1/1/2015
  • Breast Cancer-Early stage: hypofractionation and APBI 
    Adana, Turkey - 1/1/2015
  • Cardiac sparing. 
    Adana, Turkey - 1/1/2015

Other

Press Mentions

  • Triple-Negative Breast Cancer Survivor: MD Anderson Is ‘A Hospital like No Other’
    Triple-Negative Breast Cancer Survivor: MD Anderson Is ‘A Hospital like No Other’January 24th, 2023
  • Valentine’s Day Event at MD Anderson the Woodlands Spreads Love to Breast Cancer Patients and Survivors
    Valentine’s Day Event at MD Anderson the Woodlands Spreads Love to Breast Cancer Patients and SurvivorsFebruary 14th, 2020
  • Best of Cancerwise 2018: Helpful Insights from Our Experts
    Best of Cancerwise 2018: Helpful Insights from Our ExpertsDecember 19th, 2018

Committees

  • Co chair, Breast Multidisciplinary Team 2010 - Present
  • Co-chair, Bootwalk to end cancer MDA Anderson Cancer Center 2021 - 2023
  • Senator, Faculty senate 2021 - 2023
  • Champion, Service Excellence MD Anderson 2018 - 2021
  • Co-chair, Frontiers of Interdisciplinary Personalized Cancer Therapy, MDAPN, Conference 2011 - 2012

Research History

  • Collaborator, Impact of the Oncotype DX DCIS Score on Treatment Decision Making in Patients with Ductal Carcinoma in Situ, 2013-0849Genomic Health2014 - 2017
  • Collaborator, A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III NSCLC, RTOG1306Astellas Pharma and Pfizer2014 - 2017
  • CollaboratorStandard fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.2011 - 2017
  • CollaboratorXRT for rising PSA post prostatectomy, 2008-02542011 - 2017
  • Collaborator, 2nd authorConventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.2010 - 2017

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: